Osamu Sato

Pharmacokinetics, Pharmacodynamics and Safety of Tolvaptan, A Novel, Oral, Selective Nonpeptide AVP V2-receptor Antagonist: Results of Single- and Multiple-Dose Studies in Healthy Japanese Male Volunteers

Tadashi Okada, J. Azuma, T. Hasunuma, 2011, Cardiovascular Drugs and Therapy.